Condition: End-Stage Kidney Disease · End-Stage Renal Disease · Sponsor: VA Office of Research and Development
The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties). The investigators will also examine intervention practices to identify components that best support engagement and sustainability.
This description comes directly from the study's public registry record.
Christopher M Donnelly · Christopher.Donnelly2@va.gov
Jade Fiotto · (617) 232-9500 · Jade.Fiotto@va.gov
Always discuss trial participation with your own doctor first.
| VA Long Beach Healthcare System, Long Beach, CA | Long Beach, California, United States | Recruiting |
| North Florida/South Georgia Veterans Health System, Gainesville, FL | Gainesville, Florida, United States | Recruiting |
| Atlanta VA Medical and Rehab Center, Decatur, GA | Decatur, Georgia, United States | Recruiting |
| Iowa City VA Health Care System, Iowa City, IA | Iowa City, Iowa, United States | Recruiting |
| VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA | Boston, Massachusetts, United States | Not Yet Recruiting |
| Minneapolis VA Health Care System, Minneapolis, MN | Minneapolis, Minnesota, United States | Recruiting |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Omaha, Nebraska, United States | Recruiting |
| New Mexico VA Health Care System, Albuquerque, NM | Albuquerque, New Mexico, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05931276